American Psychiatric Association. 2013. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing.
Annis, H. M., and C. S. Davis. 1989. “Relapse Prevention Training: A Cognitive-Behavioral Approach Based on Self-Efficacy Theory.” Journal of Chemical Dependency Treatment 2(2): 81–103.
Astin, J. A. 1997. “Stress Reduction Through Mindfulness Meditation: Effects on Psychological Symptomatology, Sense of Control, and Spiritual Experiences.” Psychotherapy and Psychosomatics 66(2): 97–106.
Bowen, S., N. Chawla, and G. A. Marlatt. 2010. Mindfulness-Based Relapse Prevention for Addictive Behaviors: A Clinician’s Guide. New York: Guilford Press.
Bowen, S., K. Witkiewitz, S. L. Clifasefi, J. Grow, N. Chawla, S. H. Hsu, H. A. Carroll, E. Harrop, S. E. Collins, K. Lustyk, and M. E. Larimer. 2014. “Relative Efficacy of Mindfulness-Based Relapse Prevention, Standard Relapse Prevention, and Treatment as Usual for Substance Use Disorders.” JAMA Psychiatry 71(5): 547–56.
Breslin, F. C., M. Zack, and S. McMain. 2002. “An Information-Processing Analysis of Mindfulness: Implications for Relapse Prevention in the Treatment of Substance Abuse.” Clinical Psychology: Science and Practice 9(3), 275–99.
Brown, S. A., S. V. Glasner-Edwards, S. R. Tate, J. R. McQuaid, J. Chalekian, and E. Granholm. 2006. “Integrated Cognitive Behavioral Therapy Versus Twelve-Step Facilitation for Substance Dependent Adults with Depressive Disorders.” Journal of Psychoactive Drugs 38(4): 449–60.
Budney, A. J., B. A. Moore, H. L. Rocha, and S. T. Higgins. 2006. “Clinical Trial of Abstinence-Based Vouchers and Cognitive-Behavioral Therapy for Cannabis Dependence.” Journal of Consulting and Clinical Psychology 74(2): 307–16.
Carlson, L. E., M. Speca, K. D. Patel, and E. Goodey. 2004. “Mindfulness-Based Stress Reduction in Relation to Quality of Life, Mood, Symptoms of Stress and Levels of Cortisol, Dehydroepiandrosterone Sulfate (DHEAS) and Melatonin in Breast and Prostate Cancer Outpatients.” Psychoneuroendocrinology 29(4): 448–74.
Centers for Disease Control. 2015. “How Much Physical Activity Do Adults Need?” Retrieved from http://www.cdc.gov/physicalactivity/everyone/guidelines/adults.html.
Childress A. R., R. N. Ehrman, Z. Wang, Y. Li, N. Sciortino, J. Hakun, W. Jens, J. Suh, J. Listerud, K. Marquez, T. Franklin, D. Langleben, J. Detre, and C. P. O’Brien. 2008. “Prelude to Passion: Limbic Activation by Unseen Drug and Sexual Cues.” PLoS ONE 3(1): e1506.
Church S. H., J. L. Rothenberg, M. A. Sullivan, G. Bornstein, and E. V. Nunes. 2001. “Concurrent Substance Use and Outcome in Combined Behavioral and Naltrexone Therapy for Opiate Dependence.” American Journal of Drug and Alcohol Abuse 27: 441–452.
Cuijpers, P., F. Smit, and A. van Straten. 2007. “Psychological Treatments of Subthreshold Depression: A Metaanalytic Review.” Acta Psychiatrica Scandinavica 115(6), 434–41.
Daughters, S.B., A. R. Braun, M. N. Sargeant, E. K. Reynolds, D. E. Hopko, C. Blanco, and C. W. Lejuez. 2008. “Effectiveness of a Brief Behavioral Treatment for Inner-City Illicit Drug Users with Elevated Depressive Symptoms: The Life Enhancement Treatment for Substance Use (LETS ACT!).” Journal of Clinical Psychiatry 69, 122–29.
DeVito, E. E., P. D. Worhunsky, K. M. Carroll, B. J. Rounsaville, H. Kober, and M. N. Potenza. 2012. “A Preliminary Study of the Neural Effects of Behavioral Therapy for Substance Use Disorders.” Drug and Alcohol Dependence 122(3): 228–235.
Di Chiara, G., and A. Imperato. 1988. “Drugs Abused by Humans Preferentially Increase Synaptic Dopamine Concentrations in the Mesolimbic System of Freely Moving Rats.” Proceedings of the National Academy of Sciences 85(14): 5274–8.
Dobson, K. S. 2013. “The Science of CBT: Toward a Metacognitive Model of Change?” Behavior Therapy 44(2): 224–27.
Dolezal, B. A., J. Chudzynski, T. W. Storer, M. Abrazado, J. Penate, L. Mooney, D. Dickerson, R. A. Rawson, and C. B. Cooper. 2013. “Eight Weeks of Exercise Training Improves Fitness Measures in Methamphetamine-Dependent Individuals in Residential Treatment.” Journal of Addiction Medicine 7(2): 122–28.
Enoch, M. 2012. “The Influence of Gene-Environment Interactions on the Development of Alcoholism and Drug Dependence.” Current Psychiatry Reports 14(2): 150–58.
Epstein, E. E. and B. S. McCrady. 2009. Overcoming Alcohol Use Problems: A Cognitive-Behavioral Treatment Program. New York: Oxford University Press.
Evans, S., S. Ferrando, M. Findler, C. Stowell, C. Smart, and D. Haglin. 2008. “Mindfulness-Based Cognitive Therapy for Generalized Anxiety Disorder.” Journal of Anxiety Disorders 22(4): 716–21.
Farabee, D., R. Rawson, and M. McCann. 2002. “Adoption of Drug Avoidance Activities Among Patients in Contingency Management and Cognitive-Behavioral Treatments.” Journal of Substance Abuse Treatment 23: 343–50.
Glasner-Edwards, S., P. Marinelli-Casey, R. Gonzales, M. Hillhouse, A. Ang, L. J. Mooney, and R. Rawson. 2009. “Depression Among Methamphetamine Users: Association with Outcomes from the Methamphetamine Treatment Project at Three-Year Follow-Up.” Journal of Nervous and Mental Disease 197: 225–31.
Glasner-Edwards, S. L. J. Mooney, A. Ang, H. C. Garneau, E. Hartwell, M. Brecht, and R. A. Rawson. Forthcoming. “Mindfulness-Based Relapse Prevention for Stimulant Dependent Adults: A Pilot Randomized Clinical Trial.” Addiction.
Glasner-Edwards, S., L. J. Mooney, A. Ang, M. Hillhouse, and R. Rawson. 2013. “Does Post-Traumatic Stress Disorder Affect Post-Treatment Methamphetamine Use?” Journal of Dual Diagnosis 9(2): 123–28.
Green, L., and J. H. Kagel, (Eds.) 1996. Advances in Behavioral Economics, Vol. 3: Substance Use and Abuse. Norwood, NJ: Ablex.
Hanson, G. R. 2002. “New Insights into Relapse.” NIDA Notes 17:3. National Institute on Drug Abuse. National Institute of Health. U.S. Department of Health and Human Services.
Hettema, J., J. Steele, and W. R. Miller. 2005. “Motivational Interviewing.” Annual Review of Clinical Psychology 1: 91–111.
Higgins, S. T., S. M. Alessi, and R. L. Dantona. 2002. “Voucher-Based Incentives. A Substance Abuse Treatment Innovation.” Addictive Behaviors 27(6): 887–910.
Kabat-Zinn J., A. O. Massion, J. Kristeller, L. G. Peterson, K. E. Fletcher, L. Pbert, W. R. Lenderking, and S. F. Santorelli. 1992. “Effectiveness of a Meditation-Based Stress Reduction Program in the Treatment of Anxiety Disorders.” American Journal of Psychiatry 149(7): 936–43.
Kabat-Zinn J. 1982. “An Outpatient Program in Behavioral Medicine for Chronic Pain Patients Based on the Practice of Mindfulness Meditation: Theoretical Considerations and Preliminary Results.” General Hospital Psychiatry 4(1): 33–47.
Kabat-Zinn, J. 1990. Full Catastrophe Living: Using the Wisdom of Your Body and Mind to Face Stress, Pain, and Illness. New York: Delacorte.
Kabat-Zinn, J. 2003. “Mindfulness-Based Interventions in Context: Past, Present, and Future.” Clinical Psychology: Science and Practice 10(2): 144–56.
Kelly, J. F., and M.C. Greene. 2014. “Where There’s a Will There’s a Way: A Longitudinal Investigation of the Interplay Between Recovery Motivation and Self-Efficacy in Predicting Treatment Outcome.” Psychology of Addictive Behaviors 28(3): 928–34.
Kelly, J. F., B. Hoeppner, R. L. Stout, and M. Pagano. 2012. “Determining the Relative Importance of the Mechanisms of Behavior Change Within Alcoholics Anonymous: A Multiple Mediator Analysis.” Addiction 107: 289–99.
Kendler, K. S., L. M Karkowski, M. C. Neale, and C. A. Prescott. 2000. “Illicit Psychoactive Substance Use, Heavy Use, Abuse, and Dependence in a US Population-Based Sample of Male Twins.” Archives of General Psychiatry 57: 261–69.
Larimer, M. E., R. S. Palmer, and G. A. Marlatt. 1999. “Relapse Prevention. An Overview of Marlatt’s Cognitive-Behavioral Model.” Alcohol Research and Health 23(2): 151–60.
Magidson, J. F., S. M. Gorka, L. MacPherson, D. R. Hopko, C. Blanco, C. W. Lejuez, and S. B. Daughters. 2011. “Examining the Effect of the Life Enhancement Treatment for Substance Use (LETS ACT) on Residential Substance Abuse Treatment Retention.” Addictive Behaviors 36(6), 615–23.
Marlatt, G. A., and J. R. Gordon (Eds). 1985. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York: Guilford Press.
Marlatt, G. A. 1996. “Taxonomy of High-Risk Situations for Alcohol Relapse: Evolution and Development of a Cognitive-Behavioral Model.” Addiction 91(suppl): 37–49.
Marlatt, G. A. and B. D. Ostafin. 2005. “Being Mindful of Automaticity in Addiction: A Clinical Perspective.” In Handbook of Implicit Cognition and Addiction, edited by R. W. Wiers and A. W. Stacy. Thousand Oaks, CA: Sage.
Mazzucchelli, T., R. Kane, and C. Rees. 2009. “Behavioral Activation Treatments for Depression in Adults: A Meta-Analysis and Review.” Clinical Psychology: Science and Practice 16(4), 383–411.
McAuliffe W. E. 1990. “A Randomized Control Trial of Recovery Training for Opioid Addicts in New England and Hong Kong.” Journal of Psychoactive Drugs 22: 197–209.
McLellan, A. T., D. C. Lewis, C. P. O’Brien, and H. D. Kleber. 2000. “Drug Dependence, a Chronic Medical Illness: Implications for Treatment, Insurance, and Outcomes Evaluation.” JAMA. 284(13): 1689–95.
Miller, W. R. 1983. “Motivational Interviewing with Problem Drinkers.” Behavioral Psychotherapy 11: 147–72.
Miller, W. R. 1996. “Motivational Interviewing: Research, Practice, and Puzzles.” Addictive Behaviors 21(6), 835–42.
Mooney, L.J., Cooper, C., London, E.D., Chudzynski, J., Dolezal, B., Dickerson, D., Brecht, M.L., Penate, J., and Rawson, R.A. (2014). Exercise for methamphetamine dependence: rationale, design, and methodology. Contemporary Clinical Trials, 37(1): 139–47.
Morgenstern, J., E. Labouvie, B. S. McCrady, C. W. Kahler, and R. M. Frey. 1997. “Affiliation with Alcoholics Anonymous After Treatment: A Study of Its Therapeutic Effects and Mechanisms of Action.” Journal of Consulting and Clinical Psychology 65: 768–77.
NIDA (National Institute on Drug Abuse). 2010. Drugs, Brains, and Behavior: The Science of Addiction. NIH Pub No. 10–5605.
Pollack, M. H., S. A. Penava, E. Bolton, J. J. Worthington III, G. L. Allen, F. J. Farach, and M. W. Otto. 2002. “A Novel Cognitive-Behavioral Approach for Treatment-Resistant Drug Dependence.” Journal of Substance Abuse Treatment 23: 335–42.
Prochaska, J. O., C. C. DiClemente, and J. C. Norcross. 1992. “In Search of How People Change: Applications to Addictive Behaviors.” American Psychologist 47(9): 1102–14.
Ramel, W., P. R. Goldin, P. E. Carmona, and J. R. McQuaid. 2004. “The Effects of Mindfulness Meditation on Cognitive Processes and Affect in Patients with Past Depression.” Cognitive Therapy and Research 28(4): 433–55.
Rawson R. A., J. Chudzynski, L. Mooney, R. Gonzales, A. Ang, D. Dickerson, J. Penate, B. A. Salem, B. Dolezal, and C. B. Cooper. 2015. “Impact of an Exercise Intervention on Methamphetamine Use Outcomes Post-Residential Treatment Care.” Drug and Alcohol Dependence. Under review.
Rawson, R. A., P. Marinelli-Casey, M. D. Anglin, A. Dickow, Y. Frazier, C. Gallagher, G. P. Galloway, J. Herrell, A. Huber, M. J. McCann, J. Obert, S. Pennell, C. Reiber, D. Vandersloot, and J. Zweben. 2004. “A Multi-Site Comparison of Psychosocial Approaches for the Treatment of Methamphetamine Dependence.” Addiction 99(6): 708–17.
Roemer, L., and S. M. Orsillo. 2003. “Mindfulness: A Promising Intervention Strategy in Need of Further Study.” Clinical Psychology: Science and Practice 10(2): 172–78.
Rohsenow, D. J., P. M. Monti, R. A. Martin, S. M. Colby, M. G. Myers, S. B. Gulliver, R. A. Brown, T. I. Mueller, A. Gordon, and D. B. Abrams. 2004. “Motivational Enhancement and Coping Skills Training for Cocaine Abusers: Effects on Substance Use Outcomes.” Addiction 99(7): 862–74.
Shapiro, S. L., G. E. Schwartz, and G. Bonner. 1998. “Effects of Mindfulness-Based Stress Reduction on Medical and Premedical Students.” Journal of Behavioral Medicine 21(6): 581–99.
Sheff, D. 2014. “How Philip Seymour Hoffman Could Have Been Saved.” Time, Feb 2. Retrieved from http://time.com/3390/how-philip-seymour-hoffman-could-have-been-saved/
Sinha R. 2007. “The Role of Stress in Addiction Relapse.” Current Psychiatry Reports 9: 388–95.
Sinha, R. 2008. “Chronic Stress, Drug Use, and Vulnerability to Addiction.” Annals of the New York Academy of Sciences 1141, 105–30.
Stein M. D., D. S. Herman, D. A. Solomon, J. L. Anthony, B. J. Anderson, S. E. Ramsey, and I. W. Miller. 2004. “Adherence to Treatment of Depression in Active Injection Drug Users: The Minerva Study.” Journal of Substance Abuse Treatment 26, 87–93.
Sturmey, P. 2009. “Behavioral Activation Is an Evidence-Based Treatment for Depression.” Behavior Modification 33(6), 818–29.
Tate, S. R., J. Wu, J. R. McQuaid, K. Cummins, C. Shriver, M. Krenek, and S. A. Brown. 2008. “Comorbidity of Substance Dependence and Depression: Role of Life Stress and Self-Efficacy in Sustaining Abstinence.” Psychology of Addictive Behaviors 22(1): 47–57.
Timko, C., R. Billow, and A. DeBenedetti. 2006. “Determinants of 12-step Group Affiliation and Moderators of the Affiliation-Abstinence Relationship.” Drug and Alcohol Dependence 83(2): 111–21.
Tsuang, M. T., M. J. Lyons, J. M. Meyer, T. Doyle, S. A. Eisen, J. Goldberg, W. True, N. Lin, R. Toomey, and L. Eaves. 1998. “Co-Occurrence of Abuse of Different Drugs in Men: The Role of Drug-Specific and Shared Vulnerabilities.” Archives of General Psychiatry 55(11): 967–72.
Tsuang M. T., W. M. Stone, and S. V. Faraone. 2001. “Genes, Environment, and Schizophrenia.” British Journal of Psychiatry 178(40): s18–s24.
Volkow, N.D., L. Chang, G. Wang, J. S. Fowler, D. Franceschi, M. Sedler, S. J. Gatley, E. Miller, R. Hitzemann, Y. Ding, and J. Logan. 2001. “Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence.” Journal of Neruoscience 21(23): 9414–18.
Williams, K. A., M. M. Kolar, B. E. Reger, and J. C. Pearson. 2001. “Evaluation of a Wellness-Based Mindfulness Stress Reduction Intervention: A Controlled Trial.” American Journal of Health Promotion 15(6): 422–32.
Witkiewitz K., M. K. Lustyk, and S. Bowen. 2013. “Retraining the Addicted Brain: A Review of Hypothesized Neurobiological Mechanisms of Mindfulness-Based Relapse Prevention.” Psychology of Addictive Behaviors 27(2): 351–65.